
Mikacant 250mg Injection
Marketer
Medicant Lifesciences Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Mikacant 250mg Injection
Cefaclor 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (including pneumonia), brain, and bloodstream infections. Prophylactic use is also common in hospitalized individuals. Its mechanism involves bacterial growth inhibition. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional only, it requires regular, evenly-spaced doses as directed. Complete the prescribed course, regardless of symptom improvement; premature cessation risks relapse or infection exacerbation. Minor side effects may include injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity, necessitating close physician supervision, including routine kidney function, hearing, and urinalysis. Pregnancy is a contraindication; inform your doctor of pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Mikacant 250mg Injection
There is no text provided to rewrite.
Uses of Mikacant 250mg Injection
Infections caused by bacteria
Major Benefits of Mikacant 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikacant 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikacant 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Mikacant 250mg Injection works:
The injectable antibiotic Mikacant 250mg inhibits bacterial proliferation by disrupting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concomitant use of Mikacant 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Mikacant 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikacant 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
The administration of Mikacant 250mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Exercise caution when administering Mikacant 250mg Injection to individuals with impaired renal function. Dosage modification of Mikacant 250mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mikacant 250mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Mikacant 250mg Injection :
Omitting a scheduled dose of Mikacant 250mg Injection warrants contacting your physician.
Facts to Know About Mikacant 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
